Isomorphic Labs, an AI drug discovery startup spun out of Alphabet's DeepMind, is in talks to raise new funding valuing the company at $40 billion to $50 billion. This would be a significant increase from its $2.1 billion Series B round five months ago. The startup uses AI to speed up drug discovery, focusing on cancer and immune disorders, and partners with major pharma companies like Eli Lilly and Novartis. The funding talks highlight growing investor interest in AI's role beyond software, particularly in healthcare innovation.
Google's parent company, Alphabet, trades at USD 347.44 on Pluang as of Oct 08, 2026 22:22 WIB, showing a slight 0.02% increase in one day. This stable performance comes while Isomorphic Labs, an Alphabet spin-off, seeks a valuation between $40 billion and $50 billion in a new funding round. The interest in AI-driven healthcare innovation is reflected in Alphabet's significant market cap of $4.27 trillion and active trading volume of over 11 million shares on Pluang. Investors hold Google shares for an average of 137 days, indicating steady confidence in the company's long-term prospects.
Alphabet (GOOG) has secured a $10 billion private placement in Anthropic, ahead of Anthropic's highly anticipated and oversubscribed IPO valued at $1.4 trillion. This investment not only makes Alphabet an equity holder but also a beneficiary of Anthr...
Victor Dergunov downgraded Nvidia Corporation from Buy to Hold and lowered the 12-month price target to $200 from $250. Despite strong near-term chip demand and solid earnings guidance, long-term risks like CEO succession, an ongoing investigation, a...
Alphabet is rated a 'Strong Buy' due to its aggressive investments in AI, especially through its Gemini project and Google Cloud, which help maintain its dominant 90% share in search. While the company faces near-term negative free cash flow and risi...
Bernstein Liebhard LLP reminds Alphabet Inc. investors of the December 1, 2026 deadline to join a securities fraud class action lawsuit. The lawsuit alleges Alphabet made false statements about its business and financial health between May 19 and Jul...
Anthropic initially leaked an IPO price range of $70 to $80 per share but retracted it within about 80 minutes, calling the pricing details inaccurate. The official SEC filing still shows no price range, leaving valuation and share count uncertain. T...
